Medicine:Fluorescein (medical use)

From HandWiki
Fluorescein
Fluorescin in dropper.jpg
Fluorescein drops being put in the eye before examination
Clinical data
Pronunciation/ˈflʊərəsn/[1]
Trade namesFluorescite, AK-Fluor, BioGlo, others
License data
Routes of
administration
Eye drops, intravenous, by mouth
Drug classDiagnostic agent
ATC code
Legal status
Legal status
  • UK: POM (Prescription only) [2]
  • US: ℞-only
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
PDB ligand
Chemical and physical data
FormulaC20H12O5
Molar mass332.311 g·mol−1
3D model (JSmol)

Fluorescein is used to help in the diagnosis of a number of eye problems.[3] When applied as a drop or within a strip of paper to the surface of the eye it is used to help detect eye injuries such as foreign bodies and corneal abrasions.[4][5] When given by mouth or injection into a vein it is used to help evaluate the blood vessels in the back of the eye during fluorescein angiography.[3][6]

When applied to the surface of the eye, side effects may include a brief period of blurry vision and discoloration of contact lenses of the soft type.[7][3] When used by mouth or injection, side effects may include headache, nausea, and a change to the color of the skin for a brief period of time.[3] Allergic reactions may rarely occur.[3] Fluorescein is a dye which is taken up by damaged cornea such that the area appears green under cobalt blue light.[3] There is also a version that comes premixed with lidocaine.[4][8]

Fluorescein was first made in 1871.[9] It is on the World Health Organization's List of Essential Medicines.[10]

Brand names

It is also sold as a combination drug with oxybuprocaine under the brand name Altafluor Benox.[11][12]

Other animals

It is also sometimes administered to pets in multi-pet environments to determine which pet needs behavioral modification.[citation needed]

References

  1. "Fluorescein | Definition of Fluorescein by Oxford Dictionary on Lexico.com also meaning of Fluorescein". https://www.lexico.com/definition/fluorescein. 
  2. "Fluorescein sodium 100 mg/ml, solution for injection - Summary of Product Characteristics (SmPC)". 16 January 2018. https://www.medicines.org.uk/emc/product/8829/smpc. 
  3. 3.0 3.1 3.2 3.3 3.4 3.5 Duvall, Brian; Kershner, Robert M. (2006) (in en). Ophthalmic Medications and Pharmacology. 17. SLACK Incorporated. 151–8. ISBN 9781556427503. https://books.google.com/books?id=YsYi6dzIKKUC&pg=PA29. 
  4. 4.0 4.1 British national formulary : BNF 69 (69 ed.). British Medical Association. 2015. pp. 769, 772. ISBN 9780857111562. 
  5. Hamilton, Richart (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. p. 416. ISBN 9781284057560. 
  6. "Anatera 100mg/ml solution for injection - Summary of Product Characteristics (SmPC)". 10 February 2020. https://www.medicines.org.uk/emc/product/9696/smpc. 
  7. WHO Model Formulary 2008. World Health Organization. 2009. p. 314. ISBN 9789241547659. 
  8. "Minims Lidocaine & Fluorescein Summary of Product Characteristics (SmPC) - (emc)". 23 October 2017. https://www.medicines.org.uk/emc/product/154/smpc. 
  9. Bartlett, Jimmy D.; Jaanus, Siret D. (2008) (in en). Clinical Ocular Pharmacology. Elsevier Health Sciences. p. 283. ISBN 978-0750675765. https://books.google.com/books?id=Eybg7fbs65MC&pg=PA283. 
  10. World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO. 
  11. "Drug Approval Package: Altafluor Benox (fluorescein sodium and benoxinate hydrochloride ophthalmic solution)". 9 April 2018. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208582Orig1s000TOC.cfm. 
  12. "Altafluor- fluorescein sodium and benoxinate hydrochloride solution". 4 December 2017. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=54017304-e680-4129-b52a-69cb9810af76. 

External links